Rajeev Menon

11PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 14, 2026
Population Pharmacokinetics and Exposure-Response Analyses to Support Cofetuzumab Pelidotin (ABBV-647) Dose Optimization in Non-Small Cell Lung Cancer Patients.

|May 10, 2026
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With Myelofibrosis.

|Feb 26, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Telisotuzumab Vedotin in Patients With c-Met Protein Overexpressing Tumors.

Heiko Babel, Priya Brunsdon, Benjamin Engelhardt

|Jan 16, 2026
Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science.

Rajeev Menon, Emarjola Bako, Shuhan Liu

|Sep 25, 2025
Assessment of Telisotuzumab Vedotin Drug-Drug Interaction Potential Using Physiologically-Based Pharmacokinetic Modeling and Simulations.

Md Mahbubul Huq Riad, Priya Brunsdon, Rajeev Menon

|May 23, 2024
Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B-cell lymphoma-2 inhibitor.

Ahmed Hamed Salem, Rajeev M Menon

Pageof 2

Frequent Collaborators

4 joint publications

Ahmed Hamed Salem

3 joint publications

Sven Mensing

3 joint publications

Carla Biesdorf

3 joint publications

Akshanth R Polepally